Pruritus clinical trials at UCSF
2 in progress, 1 open to eligible people
Pruritus is when your skin itches a lot. UCSF is doing a study on a medicine called Linerixibat for people with pruritus from a liver problem called PBC. They want to see if the medicine is effective and safe.
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
open to eligible people ages 18-80
This is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the efficacy, safety and impact on health-related quality of life of linerixibat compared with placebo.
San Francisco, California and other locations
Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
Sorry, not accepting new patients
An open-label, single-arm, multi-centre program providing treatment access to ALGS patients with cholestatic pruritus in the US. Access can be requested through Clinigen Healthcare Ltd via email MirumALGS@clinigengroup.com or telephone +1-877-768-4303.
San Francisco, California and other locations
Our lead scientists for Pruritus research studies include Monika Sarkar.
Last updated: